Lyophilization Services for Biopharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2028
Lyophilization has been popularly employed by the pharmaceuticals industry in parenteral product development. The process has the potential to improve the shelf-life, increase the efficacy of formulations, especially complex injectables, and to make them easier to store and transport. Biopharmaceutical companies adopt lyophilization services for manufacturing sterile lyophilized bulk APIs and drug products. They are gaining popularity for complex biologics. The drive for the lyophilization services for biopharmaceuticals market stems from the inclination and efforts by the industry world over to comply with good manufacturing practices (cGMP).
Various service types can be grouped into product and cycle development, clinical manufacturing, commercial manufacturing, and freeze drying analytical services.
The need for prolonging the shelf-life of antibiotics and protein-based drug formulations is a key trend bolstering the prospect in the lyophilization services for biopharmaceuticals market. Notably, there is a persistent need to keep the biological activity of vaccines intact and the shelf-life as high as possible. The growing uptake of these in third-world countries accentuates the need. Contract manufacturing organizations have also expanded their array of lyophilization services for biopharmaceuticals. This has also expanded the outlook of the lyophilization services for biopharmaceuticals market.
Moreover, technological advances in cGMP lyophilizers have led them to assess cutting-edge lyophilizers at cost-effective rate. The uptake in the lyophilization services for biopharmaceuticals market has been underpinned by the rapid pace of the increasing demand for biological therapies for disease therapeutics in developed as well as developing regions. Over the past few years, the need for improving the shelf-life and efficacy of biologics has been substantial in emerging markets for the biopharmaceutical industry. The drive stems from the need for novel formulations for biologics in developed countries. This has propelled the demand for lyophilization services on contract basis. Automation in lyophilization has bolstered the demands for these services for topical and injectable ophthalmics over the past recent years.
Top players who want to consolidate their hold over the global lyophilization services for biopharmaceuticals market are entering into licensing agreements with their client companies. Apart from this, the strategic moves include acquisitions with the aim of expanding the manufacturing capacity both across key markets as well as in new geographies. Moreover, they are striving to adopt cutting-edge freezing methods in their units.
In recent times, a number of players have leveraged the potential of partnership to expand their new fill and finish equipment for processing sterile packaging. A case in point is West Pharmaceutical Services, Inc., a company that says it pioneers in injectable drug administration solutions, which is entering into a partnership with SCHOTT. The agreement will combine Ready Pack system of the former with the glass vials platform of the later, notably its high-quality RTU glass vials. Numerous such players are aiming to meet the customization needs through partnerships.
Some of the well-entrenched players in the lyophilization services for biopharmaceuticals market are Quality BioResources, Lyophilization Technology, LSNE Contract Manufacturing, Emergent BioSolutions Berkshire Sterile Manufacturing, Axcellerate Pharma, and Anteco Pharma.
Developed countries, such as in North America, have been at the forefront of the lyophilization services for biopharmaceuticals market. The growth of the North America market especially has been fueled by the growing body of research on biologics and protein-based therapeutics. Other developed regions are also growing in prospects in the lyophilization services for biopharmaceuticals market from the rising streams of investment in contract manufacturing services in vaccine development. Moreover, the growing regulatory approval of biologics in developing regions will offer a marked impetus in the near future.
The study presents reliable qualitative and quantitative insights into:
The regional analysis covers:
The vast market research data included in the study is the result of extensive primary and secondary research activities. Surveys, personal interviews, and inputs from industry experts form the crux of primary research activities and data collected from trade journals, industry databases, and reputable paid sources form the basis of secondary research. The report also includes a detailed qualitative and quantitative analysis of the market, with the help of information collected from market participants operating across key sectors of the market value chain. A separate analysis of macro- and micro-economic aspects, regulations, and trends influencing the overall development of the market is also included in the report.
Highlights of the report:
Note: Immense care has been taken to present data with the highest levels of accuracy in all TMRResearch reports. Nevertheless, recent developments related to market/vendor landscape may take time to reflect in the analysis.
Flat 10% discount on Single User License if you prebook this report
Flat 10% discount on Multiple User License if you prebook this report
Flat 10% discount on Corporate License if you prebook this report